The FDA issued final guidance explaining the new framework the agency will use when assigning IDE devices to one of two categories prior to clinical studies — Category A: Experimental and Category B: Nonexperimental/investigational.
Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing